Publications

This table lists examples of evidence that NDAP agencies can use as a reference in support of their conformity with the National Standards for Disability Services.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for Middle East respiratory syndrome coronavirus.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for severe acute respiratory syndrome coronavirus.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for haemophilus influenzae type b.

This booklet has been developed, together with a model trust deed, to help families who have decided to set up a Special Disability Trust.

Whether a Special Disability Trust is suitable for your purposes is a complex matter that involves the need to carefully consider your personal circumstances and those of the intended beneficiary.

This booklet explains quality assurance, and the auditing of advocacy agencies funded under the National Disability Advocacy Program (NDAP) and disability employment services. It explains the auditing process, the role of the audit team, and the role people receiving support can play in the audit.

Australian Government response to the House of Representatives Standing Committee on Health and Ageing report: Discussion paper on the late effects of polio/post-polio syndrome

The University of Canberra reviewed the Tackling Indigenous Smoking and Health Lifestyle Programme in 2014. Their series of reports focused on how to improve this program using evidence-based approaches.

These guidelines for Public Health Units provide nationally consistent guidance on how to respond to human immunodeficiency virus (HIV). They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA).

This fact sheet provides an overview of the background of the SSBA Regulatory Scheme.

This fact sheet provides information about the SSBA Regulatory Scheme’s administering body along with relevant contact details.

This fact sheet explains the emergency disease situation provisions that enable the Minister for Health, Disability and Ageing to suspend some or all regulatory obligations for handling SSBAs should there be an SSBA-related disease outbreak.

Find out how to correctly dispose of security sensitive biological agents (SSBAs).

This fact sheet gives an overview of domestic legislation that may have affect entities handling security sensitive biological agents (SSBAs).

Learn about security sensitive biological agents (SSBAs) that can be used both for good and for harm. This is known as ‘dual-use’. Exporting these SSBAs is monitored.

This fact sheets gives an overview of international conventions that may have implications for entities handling security sensitive biological agents (SSBAs).

These procedures explain how laboratories should collect and handle samples from patients with suspected viral haemorrhagic fevers.

This master plan sets out the vision for the delivery of aged care services across the Torres Strait and Northern Peninsula region. It identifies the need for integrated aged care delivery that meets the community’s needs and preferences.

This report provides advice about a national framework for continuous quality improvement in Aboriginal and Torres Strait Islander primary health care.

This fact sheet outlines which entities are exempt from the Security Sensitive Biological Agents (SSBA) Regulatory Scheme.

An evaluation from 2012 to 2014 assessed the Cape York Wellbeing Centres. It looked at whether the centres reduced alcohol and substance abuse and harm in the community. This 2014 report presents the findings.

Use this guide to help you identify some of the key requirements of tobacco plain packaging for non-cigarette products such as cigars, roll-your-own tobacco and shisha/waterpipe tobacco.

Use this guide to help you identify some of the key requirements of tobacco plain packaging.

This report presents long-term, national workforce projections for doctors to 2030. It is part of our series on Australia’s Future Health Workforce.